Related Experiment Video
Updated: Jun 9, 2026

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells
Published on: March 1, 2024
CREB inhibits AP-2alpha expression to regulate the malignant phenotype of melanoma
Vladislava O Melnikova1, Andrey S Dobroff, Maya Zigler
1Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America.
Background:
The loss of AP-2alpha and increased activity of cAMP-responsive element binding (CREB) protein are two hallmarks of malignant progression of cutaneous melanoma. However, the molecular mechanism responsible for the loss of AP-2alpha during melanoma progression remains unknown.
Methodology/Principal Findings:
Herein, we demonstrate that both inhibition of PKA-dependent CREB phosphorylation, as well as silencing of CREB expression by shRNA, restored AP-2alpha protein expression in two metastatic melanoma cell lines. Moreover, rescue of CREB expression in CREB-silenced cell lines downregulates expression of AP-2alpha. Loss of AP-2alpha expression in metastatic melanoma occurs via a dual mechanism involving binding of CREB to the AP-2alpha promoter and CREB-induced overexpression of another oncogenic transcription factor, E2F-1. Upregulation of AP-2alpha expression following CREB silencing increases endogenous p21(Waf1) and decreases MCAM/MUC18, both known to be downstream target genes of AP-2alpha involved in melanoma progression.
Conclusions/Significance:
Since AP-2alpha regulates several genes associated with the metastatic potential of melanoma including c-KIT, VEGF, PAR-1, MCAM/MUC18, and p21(Waf1), our data identified CREB as a major regulator of the malignant melanoma phenotype.
Insights
The cAMP-responsive element binding (CREB) protein drives melanoma progression by suppressing AP-2alpha. Inhibiting CREB restores AP-2alpha, impacting melanoma
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cutaneous melanoma progression is linked to AP-2alpha loss and increased cAMP-responsive element binding (CREB) protein activity.
- The molecular mechanisms behind AP-2alpha downregulation in melanoma remain unclear.
Purpose of the Study:
- To elucidate the molecular mechanism by which AP-2alpha is lost during melanoma progression.
- To investigate the role of CREB in regulating AP-2alpha expression and its impact on melanoma phenotype.
Main Methods:
- Utilized shRNA to silence CREB expression in metastatic melanoma cell lines.
- Investigated CREB binding to the AP-2alpha promoter.
- Assessed the impact of CREB modulation on downstream target genes like p21(Waf1) and MCAM/MUC18.
Main Results:
- Inhibition of CREB phosphorylation and CREB silencing restored AP-2alpha expression in metastatic melanoma cells.
- CREB binds to the AP-2alpha promoter and induces E2F-1 overexpression, leading to AP-2alpha loss.
- CREB silencing upregulated AP-2alpha, increasing p21(Waf1) and decreasing MCAM/MUC18.
Conclusions:
- CREB is identified as a key regulator of the malignant melanoma phenotype.
- AP-2alpha loss, mediated by CREB, influences melanoma metastatic potential through downstream genes.
- Targeting CREB may offer a therapeutic strategy for melanoma.
More Related Videos
12:37Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Related Concept Videos
The Intrinsic Apoptotic Pathway
Master Transcription Regulators
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
MAPK Signaling Cascades
Induced Pluripotent Stem Cells
Somatic cells are...